scholarly journals Carboplatin (Renally Dosed) and Etoposide Regimen for Small-Cell Lung Cancer

2013 ◽  
Vol 48 (4) ◽  
pp. 274-279 ◽  
Author(s):  
Matthew R. Rutledge ◽  
J. Aubrey Waddell ◽  
Dominic A. Solimando
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Malignant Diseases ◽  
Small Cell Lung ◽  
Toxic Agents

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

scholarly journals Docetaxel and Cisplatin Regimen for Non-Small-Cell Lung Cancer

2013 ◽  
Vol 48 (7) ◽  
pp. 550-557 ◽  
Author(s):  
Jessie Yang ◽  
Dominic A. Solimando ◽  
J. Aubrey Waddell
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Antineoplastic Therapy ◽  
Cancer Chemotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Malignant Diseases ◽  
Small Cell Lung ◽  
Toxic Agents

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

Topotecan for Ovarian Cancer and Small-Cell Lung Cancer

2000 ◽  
Vol 35 (3) ◽  
pp. 231-233
Author(s):  
Jennifer R. Styles ◽  
J. Aubrey Waddell ◽  
Dominic A. Solimando
Keyword(s):  
Lung Cancer ◽  
Ovarian Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Chemotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Toxic Agents

The increasing complexity of cancer chemotherapy makes it mandatory that pharmacists be familiar with these highly toxic agents. This column reviews various issues related to the preparation, dispensing, and administration of cancer chemotherapy, both commercially available and investigational.

Unresectable Non-Small Cell Lung Cancer Chemotherapy with High-Dose Cisplatin and Etoposide

Oncology ◽  
1985 ◽  
Vol 42 (4) ◽  
pp. 224-228 ◽  
Author(s):  
Giorgio V. Scagliotti ◽  
Donatella Lodico ◽  
Felice Gozzelino ◽  
Franco Bardessono ◽  
Carlo Albera ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Chemotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
High Dose ◽  
Small Cell Lung

scholarly journals PCN7 MAJOR DETERMINANTS OF COST IN ADVANCED NON-SMALL-CELL LUNG CANCER CHEMOTHERAPY REGIMES IN FRANCE

2002 ◽  
Vol 5 (6) ◽  
pp. 538-539
Author(s):  
D Tilden ◽  
M Aristides ◽  
A Kielhorn ◽  
S Bhalla
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Chemotherapy ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals Small Cell Lung Cancer Doubling Time and its Effect on Clinical Presentation: A Concise Review

2012 ◽  
Vol 6 ◽  
pp. CMO.S9633 ◽  
Author(s):  
Kassem Harris ◽  
Inga Khachaturova ◽  
Basem Azab ◽  
Theodore Maniatis ◽  
Srujitha Murukutla ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Doubling Time ◽  
Clinical Presentation ◽  
Small Cell ◽  
Malignant Diseases ◽  
Small Cell Lung ◽  
Testicular Germ Cell ◽  
Concise Review

Small cell lung cancer (SCLC) is one of many types rapidly growing malignant diseases, such as Burkitt's lymphoma and testicular germ cell cancers. At present, there is no reliable way to screen for SCLC, and imaging modalities tend to be delayed in detecting this type of cancer. The clinical presentation of acutely and rapidly growing SCLC can mimic those of pulmonary inflammatory or infectious disorders, and in some instances, this delays appropriate management and negatively affects patient outcome.

Sign in / Sign up

Export Citation Format

Share Document